CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
Through the years, many promising tools for gene editing have been developed including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), CRISPR-associated protein 9 (Cas9), and homing endonucleases (HEs). These novel technologies are now leading new scientific a...
Main Authors: | Sahar Serajian, Ehsan Ahmadpour, Sonia M. Rodrigues Oliveira, Maria de Lourdes Pereira, Siamak Heidarzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/11/1171 |
Similar Items
-
Novel CRISPR/Cas13- based assay for diagnosis of avian infectious bronchitis
by: Mahasen A. Khudeir, et al.
Published: (2024-01-01) -
A Landscape of CRISPR/Cas Technique for Emerging Viral Disease Diagnostics and Therapeutics: Progress and Prospects
by: Shyam Tripathi, et al.
Published: (2022-12-01) -
The enhancement of CRISPR/Cas9 gene editing using metformin
by: Jaedyn L. Rollins, et al.
Published: (2023-09-01) -
CRISPR/Cas9 in Chronic Lymphocytic Leukemia
by: María Hernández-Sánchez
Published: (2022-05-01) -
Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells
by: Wang, Yuanming, et al.
Published: (2018)